Overview

Nebulized Hypertonic Saline for Bronchiolitis

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Children's Hospital Los Angeles
Collaborators:
Children's Hospital & Research Center Oakland
Thrasher Research Fund
UCSF Benioff Children's Hospital Oakland